Table 4.

Patients with a VTE episode > 12 months after initial diagnosis of AAV

Characteristic	All episodes n = 14
CMV seropositive	14 (100%)
Clinical relapse at time of VTE	5 (36%)
Infection requiring hospitalisation at time of VTE	4 (29%)
Malignancy at time of VTE	3 (21%)
Median creatinine at time of VTE in μmol/L (IQR)	143 (110–188)
Median CRP at time of VTE in mg/L	42 (27–122)
Median urine ACR at time of VTE mg/mmol (IQR)	5 (1–8)
Median serum albumin at time of VTE g/L (IQR)	38 (33–46)
Median serum Hb at time of VTE g/L (IQR)	119 (93–126)
Median time to VTE event in years (IQR)	6.5 (3.4–13.0)